← Back to patent-cliff list
Ethinyl Estradiol/Gestodene
Tier C — Watch / tradeEthinyl Estradiol/Gestodene
Bayer
Originator
1995
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：ERs, PR
Brand：Femovan, Ginoden, Convaden, Katya, Apleek, Minulet, Femodene, Arianna, Lindynette, Minesse, Lisvy, Sunya, Gynera, Fedra, Melodia, Meliane
Indications (approved)：Contraception
Regional status
US
No progress
2009-05-01
EU
Approved
1995-01-01
China
No progress
2015-03-10
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Ethinyl Estradiol/Gestodene?
Approved indications include: Contraception.
When does the Ethinyl Estradiol/Gestodene patent expire?
No public expiry year is available for Ethinyl Estradiol/Gestodene yet; this page updates once verified.
How do I get a quote for Ethinyl Estradiol/Gestodene intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-04